ICM Co.
Latest round
- Series C
Last raised
- May 2019
Total raised
- $23M
Investors
- 8
About ICM Co.
, Ltd. operates as a biopharmaceutical firm that develops and manufactures gene therapeutic vectors for the treatment of degenerative diseases in patients., Ltd., Ltd. specializes in the creation of gene therapy products manufactured using the OASys production technique.7-6kb in length.
Who invested in ICM Co.
8 investors across 3 rounds
See all investors in ICM Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ICM Co.
Who invested in ICM Co.?
ICM Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ICM Co. raised?
ICM Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ICM Co. last raise money?
ICM Co.'s most recent round on record is a Series C, in May 2019.
What does ICM Co. do?
ICM Co. is a biotechnology company.
Where is ICM Co. headquartered?
ICM Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like ICM Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ICM Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ICM Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.